Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience Meeting Abstract

  

Authors:	Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; Shah, G. L.; Scordo, M.; Chung, D. J.; Landau, H. J.; Giralt, S.; Derkach, A.; Usmani, S. Z.; Lesokhin, A. M.; Tan, C. R. C.
Abstract Title:	Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680304119
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.e20005
Notes:	Meeting Abstract: e20005 -- This meeting was also held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201331